AllergyTalk
AllergyTalk delivers the latest insights and evidence shaping allergy and immunology. In each bimonthly episode, leading experts break down the most impactful research and real-world takeaways from AllergyWatch®, a bimonthly publication summarizing key findings from 20 major journals in allergy and asthma.
AllergyTalk delivers the latest insights and evidence shaping allergy and immunology. In each bimonthly episode, leading experts break down the most impactful research and real-world takeaways from AllergyWatch®, a bimonthly publication summarizing key findings from 20 major journals in allergy and asthma.
Episodes
Tuesday Jul 16, 2024
Episode 42 – What’s the Best Antibiotic for Kids With Sinusitis?
Tuesday Jul 16, 2024
Tuesday Jul 16, 2024
Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!
Today we joined by Dr. Sarah Spriet, DO, an allergist/immunologist at the Alexander T. Augusta Military Medical Center in Fort Belvoir, VA and an assistant editor of Allergy Watch. We will be reviewing the November-December 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
You can also earn CME credit by listening to this podcast! For information about CME credit or to read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
The protective effect of moderate maternal peanut consumption on peanut sensitization and allergy.
Hymenoptera venom skin testing: Adopting an accelerated test protocol.
Treatment Failure and Adverse Events After Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute Sinusitis.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Drs. Lee and Spriet have nothing to disclose
Dr. Fineman - Research: DBV, Novartis, Alladapt
Tuesday Jul 09, 2024
Episode 41 – A Promising New Treatment for SCID!
Tuesday Jul 09, 2024
Tuesday Jul 09, 2024
Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!
Today we joined by Dr. Tim Chow, an assistant professor at UT Southwestern and an assistant editor of Allergy Watch. We will be reviewing the July-August 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
You can also earn CME credit by listening to this podcast! For information about CME credit please visit https://education.acaai.org/allergytalk . To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Racial and Ethnic Disparities in Allergen Immunotherapy Prescription for Allergic Rhinitis.
Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Drs. Lee and Chow have nothing to disclose
Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Tuesday Jul 09, 2024
Episode 40 – Intranasal Epinephrine for Anaphylaxis
Tuesday Jul 09, 2024
Tuesday Jul 09, 2024
Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!
Today we joined by Dr. Tim Chow, an assistant professor at UT Southwestern and an assistant editor of Allergy Watch. We will be reviewing the July-August 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
You can also earn CME credit by listening to this podcast! For information about CME credit please visit https://education.acaai.org/allergytalk. To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: An integrated analysis.
Wildfires and the Changing Landscape of Air Pollution-related Health Burden in California.
Differences in Hypersensitivity Reactions to Iodinated Contrast Media: Analysis of the US Food and Drug Administration Adverse Event Reporting System Database.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Drs. Lee and Chow have nothing to disclose
Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Wednesday Jul 03, 2024
Episode 39: Should We Pay Teenagers to Carry Epinephrine?
Wednesday Jul 03, 2024
Wednesday Jul 03, 2024
Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!
Today we joined by Dr. Melinda Rathkopf, who is an associate professor at Emory and has had multiple leadership positions at the College, including sitting on the board of regents and chairing the Practice Management Committee. We will be reviewing the May-June 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
You can earn CME credit by listening to this podcast! For information about CME credit please visit https://education.acaai.org/allergytalk .
To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch .
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Food Allergy Management for Adolescents Using Behavioral Incentives: A Randomized Trial.
Early, continuing exposure to cow's milk formula and cow's milk allergy: The COMEET study, a single center, prospective interventional study.
Determinants of lung function across childhood in the Severe Asthma Research Program (SARP) 3.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Drs. Lee and Rathkopf have nothing to disclose
Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Wednesday Jul 03, 2024
Episode 38: Should Immunotherapy Be Offered For Atopic Dermatitis?
Wednesday Jul 03, 2024
Wednesday Jul 03, 2024
Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!
Today we are joined by Dr. Melinda Rathkopf, who is an associate professor at Emory and has had multiple leadership positions at the College, including sitting on the board of regents and chairing the Practice Management Committee. We will be reviewing the May-June 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
You can earn CME credit by listening to this podcast! For information about CME credit please visit https://education.acaai.org/allergytalk .
To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch .
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
The impact of prenatal dog keeping on infant gut microbiota development.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Drs. Lee and Rathkopf have nothing to disclose
Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Wednesday Jun 26, 2024
Wednesday Jun 26, 2024
Today we joined by Dr. Samanta Knox, MD from Gunderson Health System in La Crosse, WI where we review the Jan-Feb 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
You can earn CME credit by listening to this podcast! For information about CME credit please visit https://education.acaai.org/allergytalk
To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
Prospective evaluation of tolerance to unheated milk-boiled egg after baked milk-egg tolerance under 2 years.
Multiscale study of the oral and gut environments in children with high- and low-threshold peanut allergy.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Drs. Lee and Knox have nothing to disclose
Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Wednesday Jun 26, 2024
Episode 36: How Safe Are Oral Corticosteroids? Jan/Feb 2023
Wednesday Jun 26, 2024
Wednesday Jun 26, 2024
Today we joined by Dr. Samanta Knox, MD from Gunderson Health System in La Crosse, WI where we review the Jan-Feb 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
You can earn CME credit by listening to this podcast! For information about CME credit, go to https://education.acaai.org/allergytalk.
To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch.
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Race and ethnicity define disparate clinical outcomes in chronic rhinosinusitis.
Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study.
Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Drs. Lee and Knox have nothing to disclose
Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Thursday Jun 20, 2024
Episode 35: Can Azithromycin Help Poorly Controlled Childhood Asthma?
Thursday Jun 20, 2024
Thursday Jun 20, 2024
Originally Recorded 4/18/2023
Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!
For this episode we welcome Dr. Shyam Joshi, MD from Oregon Health and Science University and will be reviewing three articles from the Nov-Dec 2022 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
Articles Reviewed:
In Kids With Allergic Rhinitis, Remember To Address Sleep Problems!
Allergic disease, sleep problems, and psychological distress in children recruited from the general community.
Azithromycin as an Option for Poorly Controlled Childhood Asthma
Azithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial.
Data Suggest ‘Real-World Benefit’ of Early Introduction
Changes in Australian food anaphylaxis admission rates following introduction of updated allergy prevention guidelines.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Dr. Lee has nothing to disclose
Dr. Joshi has the following disclosures:
Advisory board: Takeda Leo Pharma Sanofi/Regeneron Nectar Allergy Cogent
Clinical trial funding: GlaxoSmithKline Sanofi
Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Thursday Jun 20, 2024
Episode 34: Are Nasal Polyps an Autoimmune Disease?
Thursday Jun 20, 2024
Thursday Jun 20, 2024
Originally Recorded 4/18/2023
Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!
For this episode we welcome Dr. Shyam Joshi, MD from Oregon Health and Science University and will be reviewing three articles from the Nov-Dec 2022 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
Articles Reviewed:
Combined ICS/SBA Reduces Asthma Exacerbations
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
CRSwNP Patients have Impaired Sense of Smell and Taste
Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life.
Anti-dsDNA IgG May Predict Nasal Polyp Recurrence
Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Dr. Lee has nothing to disclose
Dr. Joshi has the following disclosures:
Advisory board: Takeda Leo Pharma Sanofi/Regeneron Nectar Allergy Cogent
Clinical trial funding: GlaxoSmithKline Sanofi
Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Tuesday Jun 11, 2024
Episode 33: Are We Testing for Hymenoptera Backwards?
Tuesday Jun 11, 2024
Tuesday Jun 11, 2024
Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!
Today we joined by Dr. Vivan Hernandez-Trujillo, MD from Nicklaus Children’s Hospital in Miami, Florida where we review the July-Aug 2022 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
You can also earn CME credit by listening to this podcast! For information about CME credit or to read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Combining Discordant Serum IgE and Skin Testing Improves Diagnostic and Therapeutic Accuracy for Hymenoptera Venom Hypersensitivity Immunotherapy.
Safety of Live Attenuated Influenza Vaccine in Children With Asthma.
Obesity alters pathology and treatment response in inflammatory disease.
Please rate our podcast on iTunes!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Dr. Lee has nothing to disclose
Dr. Hernandez-Trujillo:
Speaker Takeda, CSL
Advisory boards Takeda, Regeneron, Sanofi
Consultant Kaleo, Pharming, Enzyvant, National Peanut Board, Allergy and Asthma Network
Dr. Fineman:
Speaker: Takeda; Research: Aimmune, DBV, Biocryst







